No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Verona Pharma (VRNA) Upgraded to Buy: What Does It Mean for the Stock?
Analysts Expect Breakeven For Verona Pharma Plc (NASDAQ:VRNA) Before Long
Roth MKM Initiates Verona Pharma(VRNA.US) With Buy Rating, Announces Target Price $68
Verona Pharma's Ohtuvayre: Unique COPD Solution Drives Buy Rating Amid Market Potential and Revenue Growth
Verona Pharma Is Maintained at Overweight by Wells Fargo
Verona Pharma Analyst Ratings